Ola Electric Begins Mass Deliveries of 4680 Bharat Cell-Powered Vehicles
Ola Electric has commenced mass deliveries of its 4680 Bharat Cell power vehicles, marking a significant milestone in India’s journey towards becoming a global EV hub.
Ola Electric has commenced mass deliveries of its 4680 Bharat Cell power vehicles, marking a significant milestone in India’s journey towards becoming a global EV hub.
An undisclosed institutional investor is set to offload a 0.5% stake in Eternal Ltd., the parent company of Zomato, in a block deal worth up to Rs 1,500 crore, amid increasing competition in the quick commerce space.
Bectors Food Specialities Ltd. and Bharat Rasayan Ltd. have finalised their record date for upcoming stock splits. Check the record date and understand the implications for investors.
Gold prices are expected to stay positive as investors await the US Federal Reserve’s monetary policy outcome, while silver continues to outshine gold with fresh record highs on industrial demand.
Get the latest insights on Nifty technical analysis and understand how the Dollar impacts Indian markets. Learn how to make informed investment decisions with our expert analysis.
The week ahead promises intense action on D-Street packed with domestic events, primary market buzz, corporate action, and some major global cues, which will keep investors busy after the Reserve Bank of India’s latest monetary policy verdict and quarter-point interest rate cut on Dec. 5.
Asian stocks started the week on a cautious note as traders navigate deteriorating China-Japan relations, a heavy slate of central bank decisions and the broader outlook for risk assets heading into next year.
Get the latest updates on the Indian stock market, including stocks to watch, company announcements, and market trends.
The National Stock Exchange of India (NSE) has introduced new rules for Futures and Options (F&O) trading, effective December 8, including a pre-open session for equity derivatives.
Corona Remedies and Wakefit Innovations are set to launch their IPOs, offering investors a choice between a stable pharmaceutical player and a new-age D2C sleep solutions brand. Find out which one is the better bet.